Rating History for Cellectis (CLLS) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/28/2026 | Lukas Shumway | New Coverage | Overweight (N/A) |
9.00 (N/A) |
3.67 (3.09) |
-15.8% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/28/2026 | Lukas Shumway | New Coverage | Overweight (N/A) |
9.00 (N/A) |
3.67 (3.09) |
-15.8% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||